Department of Psychiatry and Behavioral Sciences

Selected Senior Primary and Secondary Faculty Investigators

Jonathan E. Alpert MD, PhD

Novel treatments for mood disorders; depressive subtypes; research ethics and design; medical education

Julia Arnstein MD

Behavioral medicine including adherence to medication-taking, nicotine dependence, and substance abuse; addiction with comorbid chronic medical illness

Pablo Castillo MD, PhD

Excitatory and inhibitory synaptic transmission and plasticity under physiological and brain disease conditions such as Alzheimer’s disease, epilepsy, autism, schizophrenia and drug abuse

Henry Chung MD

Behavioral health integration

Chinazo Cunningham MD, MS

Access to care and health outcomes among drug users with or at-risk for HIV; buprenorphine treatment in primary care settings; opioid use, misuse, and addiction; collaborating with community-based organizations

Noboru Hiroi PhD

Genetic bases of nicotine dependence, 22q11 syndrome, and other neuropsychiatric conditions

Eric Hollander MD

Novel treatments including CBDV in Autism Spectrum Disorder (ASD); oxytocin in Prader Willi Syndrome (PWS); vasopressin 1a antagonists in ASD; alpha-1 chemotrypsin in ASD; Intermittent Explosive Disorder; Tourette Syndrome; transcranial magnetic stimulation (TMS) in OCD and ASD

Bryen A. Jordan PhD

Synaptic plasticity; RNA transport and local translation in neurons; synapse-to-nucleus signaling; proteomic analysis of the dynamics of synaptic junctions; molecular mechanisms underlying neuropsychiatric disorders.

Kamran Khodakhah PhD

Cerebellar physiology and function; cerebellar contributions to motor coordination and movement disorders as well as to other disorders including Autism, schizophrenia, addiction and migraine.

Herbert M. Lachman MD

Induced pluripotent stem cell technology to study the molecular basis of schizophrenia and autism by RNA-seq and ChIP-seq; patient-specific lines and isogenic knockout lines, generated by CRISP-Cas9.

Richard Lipton MD

Longitudinal population studies that link stress, pain and cognitive performance to genetics, biomarkers and neuroimaging

Michael L. Lipton MD, PhD

Neuroimaging; Traumatic Brain Injury (TBI); concussion injury; image processing and analysis, diffusion imaging; white matter microstructure; cognitive dysfunction

Alain Litwin MD

Models of hepatitis C virus (HCV) care for drug users; access to effective care for HCV-infected patients.

Mark Mehler MD

Stem Cell Biology and Regenerative Medicine; Epigenetics and Evolutionary Biology; Developmental Pathogenesis of Neurodegenerative Diseases; Cytokine Biology/Signal Transduction Pathways in Neurodevelopmental Disorders (Autism/ASD)

Sophie Molholm PhD

Neurobiology of development disorders, particularly autism, with focus on how the human brain processes and integrates sensory inputs to impact perception and behavior, and the role of attention.

Anne Murphy PhD

Parent-child treatment for parents with a history of abuse or neglect; creating positive social emotional and developmental outcomes for offspring of parents with trauma histories.

Shadi Nahvi MD MS

Interventions to treat tobacco use among opiate dependent patients in methadone maintenance treatment, and among other vulnerable populations

Saleem M. Nicola PhD

Electrophysiological, behavioral and pharmacological approaches to studying neural circuits underlying reward-seeking and addictive behaviors.

Patricia (Tia) Powell MD

Bioethics issues in public policy, dementia, mediation/consultation, end of life care, bioethics education and public health disasters.

Brochure

2017 Conference Brochure (PDF)

 

Surveys

2016 Survey 

 

Calendar

No upcoming events at this time.

view calendar

 

Media Spotlight

Popular Science interviews Dr. Michael Lipton on his research that found women sustain more severe brain injury than men from soccer ball heading. (Wednesday, Nov 15, 2017)

media coverage on other stories

 
Click here to log in